Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1
阿扎胞苷作为化疗的表观遗传预处理药物,对新诊断的KMT2A重排急性淋巴细胞白血病患儿安全且耐受性良好:儿童肿瘤协作组试验AALL15P1
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.285158
Guest, Erin M; Kairalla, John A; Devidas, Meenakshi; Hibbitts, Emily; Carroll, Andrew J; Heerema, Nyla A; Kubaney, Holly R; August, Margaret A; Ramesh, Sidharth; Yoo, Byunggil; Farooqi, Midhat S; Pauly, Melinda G; Wechsler, Daniel S; Miles, Rodney R; Reid, Joel M; Kihei, Cynthia D; Gore, Lia; Raetz, Elizabeth A; Hunger, Stephen P; Loh, Mignon L; Brown, Patrick A